We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$82.6M
Cap. Flow
+$147M
Cap. Flow %
6.86%
Top 10 Hldgs %
24.87%
Holding
174
New
31
Increased
73
Reduced
40
Closed
27

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$26M
2
FISV
Fiserv Inc
FISV
+$24M
3
OMC icon
Omnicom Group
OMC
+$19.5M
4
OC icon
Owens Corning
OC
+$19.2M
5
MOS icon
The Mosaic Company
MOS
+$18.3M

Top Sells

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$24.3M
2
BKH icon
Black Hills Corp
BKH
+$19.6M
3
SEE
Sealed Air
SEE
+$15.5M
4
UHS icon
Universal Health Services
UHS
+$15M
5
GOLD
Gold.com Inc
GOLD
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 20.83%
2 Healthcare 17.07%
3 Consumer Discretionary 14.96%
4 Materials 11.78%
5 Industrials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
1
Viatris
VTRS
$20.8B
$69.6M 3.24%
5,593,608
+180,499
+3% +$1.95M
GPN icon
2
Global Payments
GPN
$23.9B
$61.7M 2.87%
797,496
+116,402
+17% +$9.37M
XRAY icon
3
Dentsply Sirona
XRAY
$2.7B
$58.7M 2.73%
5,132,036
+780,837
+18% +$9.17M
AKAM icon
4
Akamai
AKAM
$16.3B
$58.6M 2.73%
671,569
+172,472
+35% +$14.2M
AZO icon
5
PUT
AutoZone
AZO
$50.9B
$54.3M 2.53%
+16,000
New +$60.4M
EGO icon
6
Eldorado Gold
EGO
$8.4B
$53.7M 2.5%
1,496,283
-382,819
-20% -$11.5M
ACHC icon
7
Acadia Healthcare
ACHC
$3.01B
$47M 2.19%
3,312,043
+1,375,647
+71% +$26M
RNG icon
8
RingCentral
RNG
$4.77B
$44.4M 2.07%
1,538,034
+55,587
+4% +$1.58M
PVH icon
9
PVH
PVH
$4.01B
$43.8M 2.04%
652,967
+159,532
+32% +$12.5M
EQX icon
10
Equinox Gold
EQX
$7.22B
$42.5M 1.98%
3,027,489
+50,279
+2% +$634K
TFX icon
11
Teleflex
TFX
$5.94B
$42.3M 1.97%
346,559
-39,113
-10% -$4.74M
ST icon
12
Sensata Technologies
ST
$6.8B
$40.5M 1.89%
1,217,415
+45,160
+4% +$1.44M
BILL icon
13
BILL Holdings
BILL
$4.62B
$38.7M 1.8%
708,912
+68,990
+11% +$3.54M
SON icon
14
Sonoco
SON
$5.99B
$38M 1.77%
871,442
+27,991
+3% +$1.16M
OMC icon
15
Omnicom Group
OMC
$24.6B
$36.8M 1.71%
455,671
+255,765
+128% +$19.5M
CNXC icon
16
Concentrix
CNXC
$1.55B
$36.4M 1.69%
874,241
+51,896
+6% +$2.11M
MTB icon
17
M&T Bank
MTB
$36.6B
$35.2M 1.64%
174,507
+27,540
+19% +$5.26M
IOVA icon
18
Iovance Biotherapeutics
IOVA
$2.1B
$32.6M 1.52%
11,959,505
+1,417,897
+13% +$3.28M
CLVT icon
19
Clarivate
CLVT
$1.53B
$30.2M 1.4%
9,029,414
+326,369
+4% +$1.16M
CNMD icon
20
CONMED
CNMD
$1.33B
$29.9M 1.39%
737,546
+317,543
+76% +$13.8M
DV icon
21
DoubleVerify
DV
$1.73B
$27.3M 1.27%
2,383,935
+575,030
+32% +$6.34M
LEG icon
22
Leggett & Platt
LEG
$1.47B
$26.8M 1.25%
2,437,519
+93,213
+4% +$917K
ABM icon
23
ABM Industries
ABM
$2.88B
$26.6M 1.24%
629,452
+129,614
+26% +$5.7M
TNC icon
24
Tennant Co
TNC
$1.5B
$24.4M 1.14%
331,174
+1,259
+0.4% +$96.2K
DOLE icon
25
Dole
DOLE
$1.35B
$23.9M 1.11%
1,597,451
+56,492
+4% +$787K
1
2 3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Invenomic Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Invenomic Capital Management held 174 positions worth $2.15B, up 4% from $2.07B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $147M of net new capital in Q4 2025, opening 31 new positions and adding to 73 existing holdings. Its largest new stake was Fiserv Inc: 287,266 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $13.2M trimmed.

  • Invenomic Capital Management's largest Q4 2025 buy was Fiserv Inc: 287,266 shares worth $19.3M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q4 2025, an estimated $26M increase.
  • Invenomic Capital Management's biggest Q4 2025 reduction was Verizon, cutting an estimated $13.2M.
  • Invenomic Capital Management fully exited Haemonetics in Q4 2025, selling an estimated $24.3M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.15B portfolio in Q4 2025.
  • Invenomic Capital Management opened 31 new positions and closed 27 in Q4 2025.
  • Invenomic Capital Management's portfolio value rose 4% quarter-over-quarter to $2.15B.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.